Johnson & Johnson BDR (JNJB34) Stock Price & News

JNJB34:BVMF

Johnson & Johnson BDR

R$87.40

+0.74%

(+0.64) 1D

Oct 8, 5:06:00 PM GMT-3 · BRL

All symbols

	Symbol	Price	Change	% Change

Next call in 5 days

Tue, Oct 13, 2:30 PM

Fiscal period

Q3 2026

EPS / Est. (USD)

- / $2.51

Revenue / Est. (USD)

- / 25.38B

Fiscal Q3 2026 earnings call

Waiting for the earnings call

At a glance: upcoming earnings

Insights from the latest news and reports

Previous reportsAll values in USD

Loading Previous Earnings...

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	23.99B	24.56B	24.06B	25.31B
Cost of goods sold	7.29B	7.81B	8.09B	8.02B
Cost of revenue	7.29B	7.81B	8.09B	8.02B
Research and development expenses	3.67B	4.25B	3.53B	3.65B
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	5.78B	6.61B	5.85B	6.25B
Operating expense	9.46B	10.86B	9.38B	9.91B
Total operating expenses	16.75B	18.68B	17.47B	17.92B
Operating income	7.25B	5.89B	6.60B	7.39B
Other non operating income	17.00M	396.00M	-211.00M	110.00M
EBT including unusual items	7.49B	4.97B	5.99B	6.75B
EBT excluding unusual items	7.27B	6.03B	6.41B	7.42B
Income tax expense	2.34B	-150.00M	755.00M	1.21B
Effective tax rate	31.24%	-3.02%	12.60%	17.98%
Other operating expenses	-	-	-	-
Net income	5.15B	5.12B	5.24B	5.53B
Net profit margin	21.47%	20.83%	21.76%	21.86%
Earnings per share	2.80	2.46	2.70	2.90
Interest and investment income	227.00M	237.00M	229.00M	219.00M
Interest expense	-245.00M	-214.00M	-272.00M	-281.00M
Net interest expenses	-18.00M	23.00M	-43.00M	-62.00M
Depreciation and amortization charges	-	-	-	-
EBITDA	9.02B	7.90B	8.60B	9.35B
Gain or loss from assets sale	-57.00M	-132.00M	12.00M	-55.00M

Finance